Recruiting studies: Oligometastatic Gastric Adenocarcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Ca
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT03161522 PIPAC in Multimodal Therapy for Patients with Oligometastatic Peritoneal Gastric Cancer
Phase 3 · 1 location(s) · Azienda Ospedaliera Universitaria Integrata Verona · NCT05303714 Timing of Minimally Invasive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric
Phase 2/Phase 3 · 2 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT07000253 Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer
Phase 2 · 1 location(s) · Fudan University · NCT06121700

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.